All News

Helsinn Holding SA, a privately-owned pharmaceutical company, is to establish a centre of excellence in R&D of oral solid dosage at its existing site in Dublin.

As governments direct stimulus packages towards science and research, don’t forget the current crop of spin-outs who face extinction in a frozen capital market, writes Nuala Moran.

Money may be tight, but there a newcomer looking to put seed investment into innovative companies – and which aims to make funding decisions within 10 weeks.

ERC head Fotis Kafatos urges basic research for economic growth – and charts a course for expansion.

Under a new deal, Framework Programme 7 funding will be diverted to help revive Europe’s devastated automobile, manufacturing and construction sectors.